- Home
- WH vs LNTH Comparison
WH vs LNTH Comparison
Compare WH & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WH
- LNTH
- Stock Information
- Founded
- WH 2017
- LNTH 1956
- Country
- WH United States
- LNTH United States
- Employees
- WH N/A
- LNTH N/A
- Industry
- WH Hotels/Resorts
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- WH Consumer Discretionary
- LNTH Health Care
- Exchange
- WH Nasdaq
- LNTH Nasdaq
- Market Cap
- WH 6.5B
- LNTH 7.5B
- IPO Year
- WH N/A
- LNTH 2015
- Fundamental
- Price
- WH $79.34
- LNTH $79.19
- Analyst Decision
- WH Strong Buy
- LNTH Strong Buy
- Analyst Count
- WH 11
- LNTH 5
- Target Price
- WH $108.07
- LNTH $133.80
- AVG Volume (30 Days)
- WH 967.1K
- LNTH 1.0M
- Earning Date
- WH 07-23-2025
- LNTH 07-30-2025
- Dividend Yield
- WH 2.08%
- LNTH N/A
- EPS Growth
- WH 48.31
- LNTH N/A
- EPS
- WH 4.22
- LNTH 3.53
- Revenue
- WH $1,416,000,000.00
- LNTH $1,536,699,000.00
- Revenue This Year
- WH $7.69
- LNTH $4.63
- Revenue Next Year
- WH $6.55
- LNTH $9.35
- P/E Ratio
- WH $18.64
- LNTH $22.44
- Revenue Growth
- WH 2.61
- LNTH 12.53
- 52 Week Low
- WH $70.08
- LNTH $73.11
- 52 Week High
- WH $113.07
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- WH 38.17
- LNTH 44.57
- Support Level
- WH $78.82
- LNTH $76.34
- Resistance Level
- WH $81.83
- LNTH $84.36
- Average True Range (ATR)
- WH 1.82
- LNTH 2.69
- MACD
- WH -0.31
- LNTH 0.66
- Stochastic Oscillator
- WH 11.67
- LNTH 48.07
About WH Wyndham Hotels & Resorts Inc.
As of Dec. 31, 2024, Wyndham Hotels & Resorts operates 903,000 rooms across more than 20 brands predominantly in the economy and midscale segments. Super 8 is the largest brand, representing around 18% of all rooms, with Days Inn (13%) and Ramada (14%) the next two largest brands. During the past several years, the company has expanded its extended stay/lifestyle brands, which appeal to travelers seeking to experience the local culture of a given location. The company closed its La Quinta acquisition in the second quarter of 2018, adding around 90,000 rooms at the time the deal closed. Wyndham launched a new extended stay economy scale segment concept, ECHO, in the spring of 2022. The United States represents 56% of total rooms.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.